Mai Capital Management Merck & Co., Inc. Transaction History

Mai Capital Management

$10.1 Billion
Q3 2024

A detailed history of Mai Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mai Capital Management holds 164,913 shares of MRK stock, worth $16.2 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

164,913

Previous 182,407 9.59%

Holding current value

$16.2 Million

Previous $22.6 Million 17.07%

% of portfolio

0.18%

Previous 0.23%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$111.15 - $128.97 $1.94 Million - $2.26 Million	-17,494 Reduced 9.59%	164,913 $18.7 Million
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $206,250 - $221,511	1,666 Added 0.92%	182,407 $22.6 Million
Q1 2024 May 08, 2024	BUY	$113.24 - $131.95 $2.93 Million - $3.41 Million	25,836 Added 16.68%	180,741 $23.8 Million
Q4 2023 Feb 09, 2024	BUY	$100.18 - $109.02 $53,696 - $58,434	536 Added 0.35%	154,905 $16.9 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $97,596 - $108,384	-948 Reduced 0.61%	154,369 $15.9 Million
Q2 2023 Aug 02, 2023	BUY	$108.61 - $118.38 $256,645 - $279,731	2,363 Added 1.54%	155,317 $17.9 Million
Q1 2023 May 10, 2023	BUY	$102.94 - $114.86 $118,175 - $131,859	1,148 Added 0.76%	152,954 $16.3 Million
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $469,377 - $601,806	-5,368 Reduced 3.42%	151,806 $16.8 Million
Q3 2022 Nov 15, 2022	BUY	$84.53 - $94.96 $2.22 Million - $2.49 Million	26,249 Added 20.05%	157,174 $13.5 Million
Q2 2022 Jul 19, 2022	SELL	$83.49 - $94.64 $88,499 - $100,318	-1,060 Reduced 0.8%	130,925 $11.9 Million
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $595,578 - $667,604	-8,102 Reduced 5.78%	131,985 $10.8 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $16,696 - $20,914	231 Added 0.17%	140,087 $10.7 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $2,795 - $3,074	-39 Reduced 0.03%	139,856 $10.5 Million
Q2 2021 Jul 19, 2021	SELL	$70.31 - $77.77 $413,422 - $457,287	-5,880 Reduced 4.03%	139,895 $10.9 Million
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $1.47 Million - $1.73 Million	-21,338 Reduced 12.77%	145,775 $11.2 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $41,411 - $45,958	-577 Reduced 0.34%	167,113 $13.7 Million
Q3 2020 Oct 26, 2020	SELL	$73.18 - $82.95 $886,136 - $1 Million	-12,109 Reduced 6.73%	167,690 $13.9 Million
Q2 2020 Jul 27, 2020	BUY	$70.42 - $80.13 $412,238 - $469,081	5,854 Added 3.37%	179,799 $13.9 Million
Q1 2020 Apr 16, 2020	SELL	$63.36 - $87.82 $199,013 - $275,842	-3,141 Reduced 1.77%	173,945 $13.4 Million
Q4 2019 Feb 03, 2020	BUY	$77.58 - $87.54 $6.4 Million - $7.22 Million	82,531 Added 87.28%	177,086 $16.1 Million
Q3 2019 Oct 29, 2019	BUY	$76.08 - $82.93 $331,860 - $361,740	4,362 Added 4.84%	94,555 $7.96 Million
Q2 2019 Aug 15, 2019	BUY	$69.84 - $81.59 $326,990 - $382,004	4,682 Added 5.48%	90,193 $7.56 Million
Q1 2019 Apr 29, 2019	BUY	$69.58 - $79.36 $44,461 - $50,711	639 Added 0.75%	85,511 $7.11 Million
Q4 2018 Jan 30, 2019	BUY	$65.24 - $75.71 $481,666 - $558,966	7,383 Added 9.53%	84,872 $6.49 Million
Q3 2018 Oct 12, 2018	BUY	$57.69 - $67.84 $56,536 - $66,483	980 Added 1.28%	77,489 $5.5 Million
Q2 2018 Aug 16, 2018	BUY	$50.83 - $59.72 $87,681 - $103,017	1,725 Added 2.31%	76,509 $4.64 Million
Q1 2018 Apr 17, 2018	BUY	$50.96 - $59.23 $199,916 - $232,359	3,923 Added 5.54%	74,784 $4.07 Million
Q4 2017 Jan 30, 2018	BUY	$51.62 - $61.64 $681,745 - $814,079	13,207 Added 22.91%	70,861 $3.99 Million
Q3 2017 Oct 12, 2017	BUY	$58.67 - $63.13 $106,544 - $114,644	1,816 Added 3.25%	57,654 $3.69 Million
Q2 2017 Aug 07, 2017	BUY	N/A	55,838	55,838 $3.58 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account

Mai Capital Management Merck & Co., Inc. Transaction History